Cancer Guide Blog: Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Treating Rare Breast Cancer With Radiation Therapy May Lower Recurrence Rate
http://www.medicalnewstoday.com/articles/114777.php
Patients with a rare type of breast cancer may benefit from receiving radiation therapy in addition to surgery to prevent recurrence, according to a study in the July issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.

----------------------------------------------
** CANCER / ONCOLOGY News **

Long Term Pegylated Interferon Alfa-2b Therapy In Stage III Melanoma Demonstrated Significant And Sustained Impact On Relapse-Free Survival
http://www.medicalnewstoday.com/articles/114772.php
Schering-Plough (NYSE: SGP) and the EORTC announced that long-term treatment with pegylated interferon alfa-2b in stage III melanoma patients had a significant and sustained impact on relapse-free survival (RFS), according to results of a randomized phase III trial published in The Lancet.

BioAlliance Pharma Launches Loramyc(R) In The UK, Germany And Denmark
http://www.medicalnewstoday.com/articles/114750.php
BioAlliance Pharma SA (Euronext Paris - BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, announced the launch of its lead product Loramyc® on the British, German and Danish markets.

UAB Joins Elite Brain Cancer Research Group
http://www.medicalnewstoday.com/articles/114585.php

Brain cancer experts at the University of Alabama at Birmingham (UAB) have been selected for membership in the Ivy Genomics-Based Medicine Project. The project is a national consortium of cutting-edge hospitals and academic centers working to improve treatment and survival for patients with a kind of malignant brain tumor called a glioma.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **